Related Experiment Video
Updated: Aug 9, 2026
Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
Published on: April 10, 2019
Therapeutics in duchenne muscular dystrophy
1Pediatric Muscular Dystrophy Association Clinic, University of California, San Francisco, USA. stroberj@neuropeds.ucsf.edu
Abstract:
Duchenne muscular dystrophy (DMD) is a fatal disorder affecting approximately 1 in 3,500 live born males, characterized by progressive muscle weakness. Several different strategies are being investigated in developing a cure for this disorder. Until a cure is found, therapeutic and supportive care is essential in preventing complications and improving the afflicted child's quality of life. Currently, corticosteroids are the only class of drug that has been extensively studied in this condition, with controversy existing over the use of these drugs, especially in light of the multiple side effects that may occur. The use of nutritional supplements has expanded in recent years as researchers improve our abilities to use gene and stem cell therapies, which will hopefully lead to a cure soon. This article discusses the importance of therapeutic interventions in children with DMD, the current debate over the use of corticosteroids to treat this disease, the growing use of natural supplements as a new means of treating these boys and provides an update on the current state of gene and stem cell therapies.
Insights
Duchenne muscular dystrophy (DMD) management involves corticosteroids, nutritional supplements, and emerging gene/stem cell therapies. While corticosteroids have side effects, supportive care and novel treatments are crucial for improving quality of life.
Area of Science:
- Neurology
- Genetics
- Pediatrics
Background:
- Duchenne muscular dystrophy (DMD) is a severe genetic disorder causing progressive muscle weakness in males.
- Current management focuses on supportive care and symptom management due to the lack of a definitive cure.
Purpose of the Study:
- To review therapeutic interventions for Duchenne muscular dystrophy.
- To discuss the ongoing debate regarding corticosteroid use and side effects.
- To explore the role of nutritional supplements and advancements in gene and stem cell therapies for DMD.
Main Methods:
- Literature review of current therapeutic strategies for DMD.
- Analysis of the efficacy and risks associated with corticosteroid treatment.
- Overview of emerging gene and stem cell therapy research.
Main Results:
- Corticosteroids are the primary pharmacological treatment, but their use is debated due to side effects.
- Nutritional supplements are increasingly utilized to complement conventional therapies.
- Gene and stem cell therapies show promise as future curative options.
Conclusions:
- Comprehensive management of DMD requires a multi-faceted approach.
- Balancing treatment benefits against side effects is critical.
- Advancements in regenerative medicine offer hope for future Duchenne muscular dystrophy cures.
Related Concept Videos
01:21Satellite Stem Cells and Muscular Dystrophy
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
01:31Skeletal Muscle Relaxants: Therapeutic Uses
01:20Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:26Heart Failure Drugs: Inotropic Agents
01:28Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...